These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 32041276)

  • 1. A Review of Small Molecule Inhibitors and Functional Probes of Human Cathepsin L.
    Dana D; Pathak SK
    Molecules; 2020 Feb; 25(3):. PubMed ID: 32041276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell penetrable, clickable and tagless activity-based probe of human cathepsin L.
    Dana D; Garcia J; Bhuiyan AI; Rathod P; Joo L; Novoa DA; Paroly S; Fath KR; Chang EJ; Pathak SK
    Bioorg Chem; 2019 Apr; 85():505-514. PubMed ID: 30802807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of new peptide amides as selective cathepsin L inhibitors: the first step towards selective irreversible inhibitors?
    Torkar A; Lenarčič B; Lah T; Dive V; Devel L
    Bioorg Med Chem Lett; 2013 May; 23(10):2968-73. PubMed ID: 23562595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An efficient and concise synthesis of a selective small molecule non-peptide inhibitor of cathepsin L: KGP94.
    Munikishore R; Wang LL; Zhang S; Zhao QS; Zuo Z
    Bioorg Chem; 2021 Nov; 116():105317. PubMed ID: 34488126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small-molecule inhibitors of cathepsin L incorporating functionalized ring-fused molecular frameworks.
    Song J; Jones LM; Chavarria GE; Charlton-Sevcik AK; Jantz A; Johansen A; Bayeh L; Soeung V; Snyder LK; Lade SD; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem Lett; 2013 May; 23(9):2801-7. PubMed ID: 23540644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clickable, selective, and cell-permeable activity-based probe of human cathepsin B - Minimalistic approach for enhanced selectivity.
    Bhuiyan AI; Rathod P; Ghoshal S; Dana D; Das T; Li G; Dickson AA; Rafi F; Subramaniam GS; Fath KR; Paroly S; Chang EJ; Pathak SK
    Bioorg Chem; 2021 Dec; 117():105463. PubMed ID: 34753058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin B and L inhibitors: a patent review (2010 - present).
    Li YY; Fang J; Ao GZ
    Expert Opin Ther Pat; 2017 Jun; 27(6):643-656. PubMed ID: 27998201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel cathepsin inhibitors with potent anti-metastatic effects in breast cancer cells.
    Yuan L; Sheng L; He W; Zou C; Hu B; Liu J; Ge W; Liu Y; Wang J; Ma E
    Bioorg Chem; 2018 Dec; 81():672-680. PubMed ID: 30253340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A small-molecule oxocarbazate inhibitor of human cathepsin L blocks severe acute respiratory syndrome and ebola pseudotype virus infection into human embryonic kidney 293T cells.
    Shah PP; Wang T; Kaletsky RL; Myers MC; Purvis JE; Jing H; Huryn DM; Greenbaum DC; Smith AB; Bates P; Diamond SL
    Mol Pharmacol; 2010 Aug; 78(2):319-24. PubMed ID: 20466822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay.
    Elshabrawy HA; Fan J; Haddad CS; Ratia K; Broder CC; Caffrey M; Prabhakar BS
    J Virol; 2014 Apr; 88(8):4353-65. PubMed ID: 24501399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biochemical evaluation of benzoylbenzophenone thiosemicarbazone analogues as potent and selective inhibitors of cathepsin L.
    Parker EN; Song J; Kishore Kumar GD; Odutola SO; Chavarria GE; Charlton-Sevcik AK; Strecker TE; Barnes AL; Sudhan DR; Wittenborn TR; Siemann DW; Horsman MR; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem; 2015 Nov; 23(21):6974-92. PubMed ID: 26462052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential cathepsin responses to inhibitor-induced feedback: E-64 and cystatin C elevate active cathepsin S and suppress active cathepsin L in breast cancer cells.
    Wilder CL; Walton C; Watson V; Stewart FAA; Johnson J; Peyton SR; Payne CK; Odero-Marah V; Platt MO
    Int J Biochem Cell Biol; 2016 Oct; 79():199-208. PubMed ID: 27592448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic insights into mode of action of novel natural cathepsin L inhibitors.
    Tyagi C; Grover S; Dhanjal J; Goyal S; Goyal M; Grover A
    BMC Genomics; 2013; 14 Suppl 8(Suppl 8):S10. PubMed ID: 24564425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective imaging of cathepsin L in breast cancer by fluorescent activity-based probes.
    Poreba M; Rut W; Vizovisek M; Groborz K; Kasperkiewicz P; Finlay D; Vuori K; Turk D; Turk B; Salvesen GS; Drag M
    Chem Sci; 2018 Feb; 9(8):2113-2129. PubMed ID: 29719685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and structure-activity relationship studies of small molecule inhibitors of the human cathepsin D.
    Goyal S; Patel KV; Nagare Y; Raykar DB; Raikar SS; Dolas A; Khurana P; Cyriac R; Sarak S; Gangar M; Agarwal AK; Kulkarni A
    Bioorg Med Chem; 2021 Jan; 29():115879. PubMed ID: 33271453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted protein degradation as a powerful research tool in basic biology and drug target discovery.
    Wu T; Yoon H; Xiong Y; Dixon-Clarke SE; Nowak RP; Fischer ES
    Nat Struct Mol Biol; 2020 Jul; 27(7):605-614. PubMed ID: 32541897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of a novel and selective cathepsin L inhibitor with anti-metastatic ability in vitro and in vivo against breast cancer cells.
    Li Y; Ai X; Zou C; Liu Y; Ma L; Men J; Liu D; Sheng L; Ruan X; Liu H; Li W; Ma E; Yuan L
    Bioorg Chem; 2021 Oct; 115():105256. PubMed ID: 34426153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functionalized benzophenone, thiophene, pyridine, and fluorene thiosemicarbazone derivatives as inhibitors of cathepsin L.
    Kumar GD; Chavarria GE; Charlton-Sevcik AK; Yoo GK; Song J; Strecker TE; Siim BG; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6610-5. PubMed ID: 20933415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the Interactions of Fasciola hepatica Cathepsin L3 with a Substrate and Potential Novel Inhibitors through In Silico Approaches.
    Hernández Alvarez L; Naranjo Feliciano D; Hernández González JE; Soares RO; Barreto Gomes DE; Pascutti PG
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003759. PubMed ID: 25978322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel role of cathepsin L for neuropeptide production illustrated by research strategies in chemical biology with protease gene knockout and expression.
    Funkelstein L; Hook V
    Methods Mol Biol; 2011; 768():107-25. PubMed ID: 21805239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.